# Intravenous Versus Topical Administration of Low Dose Epinephrine Plus Combined Administration of Intravenous and Topical Tranexamic Acid (TXA)for Primary Total Knee Arthroplasty

> **NCT02860221** · NA · UNKNOWN · sponsor: **Southwest Hospital, China** · enrollment: 210 (estimated)

## Conditions studied

- Blood Loss

## Interventions

- **DRUG:** Tranexamic acid (TXA)
- **DRUG:** Epinephrine

## Key facts

- **NCT ID:** NCT02860221
- **Lead sponsor:** Southwest Hospital, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2017-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02860221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02860221, "Intravenous Versus Topical Administration of Low Dose Epinephrine Plus Combined Administration of Intravenous and Topical Tranexamic Acid (TXA)for Primary Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02860221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*